Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Coordination Chemistry Reviews|March 28, 2012
Comparative Genomics and Evolution of Molybdenum UtilizationYan Zhang, Steffen Rump, Vadim N GladyshevThe Biochemical Journal|October 19, 2011
Identification of persulfide-binding and disulfide-forming cysteine residues in the NifS-like domain of the molybdenum cofactor sulfurase ABA3 by cysteine-scanning mutagenesisMarkus Lehrke, Steffen Rump, Torsten Heidenreich, et al.European Heart Journal. Imaging Methods and Practice|August 5, 2025
MiR-132 inhibition improves myocardial strain in a large animal model of chronic left ventricular adverse remodellingSandor Batkai, Andreas Spannbauer, Janika Viereck, et al.Cells|March 8, 2020
The Pyrazolo[3,4-d]pyrimidine Derivative, SCO-201, Reverses Multidrug Resistance Mediated by ABCG2/BCRPSophie E B Ambjørner, Michael Wiese, Sebastian Christoph Köhler, et al.European Heart Journal|November 27, 2020
Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled studyJörg Täubel, Wilfried Hauke, Steffen Rump, et al.European Journal of Heart Failure|January 25, 2024
Efficacy and safety of CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: Rationale and design of the HF-REVERT trialJohann Bauersachs, Scott D Solomon, Stefan D Anker, et al.European Heart Journal|October 22, 2020
CDR132L improves systolic and diastolic function in a large animal model of chronic heart failureSandor Batkai, Celina Genschel, Janika Viereck, et al.Biomedicines|August 6, 2021
Classical Xanthinuria in Nine Israeli Families and Two Isolated Cases from Germany: Molecular, Biochemical and Population Genetics AspectsHava Peretz, Ayala Lagziel, Florian Bittner, et al.Nature Communications|February 2, 2020
Preclinical development of a miR-132 inhibitor for heart failure treatmentAriana Foinquinos, Sandor Batkai, Celina Genschel, et al.Pageof 1